Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
C108307-1g | 1g | In stock | $19.90 | |
C108307-5g | 5g | In stock | $82.90 | |
C108307-25g | 25g | In stock | $373.90 | |
C108307-100g | 100g | In stock | $1,344.90 |
Specific NF-κB inhibitor
Synonyms | caffeic acid|3,4-Dihydroxycinnamic acid|331-39-5|trans-caffeic acid|501-16-6|3,4-Dihydroxybenzeneacrylic acid|3-(3,4-dihydroxyphenyl)acrylic acid|(E)-3-(3,4-dihydroxyphenyl)acrylic acid|(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid|Caffeicacid|Cinnamic ac |
---|---|
Specifications & Purity | Moligand™, ≥99% |
Biochemical and Physiological Mechanisms | Specific NF-κB inhibitor (IC 50 = 8.8 μM). Antioxidant, immunomodulatory and anti-inflammatory effects in vitro and in vivo . Additionally inhibits HDAC (IC 50 = 0.85 mM). Blood-brain barrier permeable. |
Storage Temp | Store at 2-8°C,Argon charged |
Shipped In | Wet ice |
Grade | Moligand™ |
Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Product Description | Caffeic Acid is an endogenous phenolic phytochemical compound that exists in plants and many foods. A major metabolite product upon hydrolization of chlorogenic acid caffeic acid inhibits a number of lipoxygenases such as 5-LO (5-lipoxygenase), in a non-competitive manner, and 12-LO (12-lipoxygenase) inhibiting leukotriene synthesis resulting in further inhibition of immunoregulation. Caffeic Acid has also been shown to inhibit arachidonic acid metabolism in platelets at high doses. It has been observed to stimulate prostaglandin synthesis at high doses. Caffeic Acid is an inhibitor of GST, ODC, Tyk and Xanthine Oxidase. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | (E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid |
---|---|
INCHI | InChI=1S/C9H8O4/c10-7-3-1-6(5-8(7)11)2-4-9(12)13/h1-5,10-11H,(H,12,13)/b4-2+ |
InChi Key | QAIPRVGONGVQAS-DUXPYHPUSA-N |
Canonical SMILES | C1=CC(=C(C=C1C=CC(=O)O)O)O |
Isomeric SMILES | C1=CC(=C(C=C1/C=C/C(=O)O)O)O |
WGK Germany | 3 |
RTECS | GD8950000 |
Alternate CAS | 501-16-6 |
PubChem CID | 689043 |
Molecular Weight | 180.16 |
Beilstein | 1954563 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
E2428199 | Certificate of Analysis | May 16, 2024 | C108307 |
E2428184 | Certificate of Analysis | May 16, 2024 | C108307 |
E2428170 | Certificate of Analysis | May 16, 2024 | C108307 |
C2405285 | Certificate of Analysis | Feb 02, 2024 | C108307 |
C2405286 | Certificate of Analysis | Feb 02, 2024 | C108307 |
C2405287 | Certificate of Analysis | Feb 02, 2024 | C108307 |
C2405289 | Certificate of Analysis | Feb 02, 2024 | C108307 |
C2405301 | Certificate of Analysis | Feb 02, 2024 | C108307 |
C2405302 | Certificate of Analysis | Feb 02, 2024 | C108307 |
A2412099 | Certificate of Analysis | Jan 20, 2024 | C108307 |
H2330215 | Certificate of Analysis | Aug 16, 2023 | C108307 |
H2330216 | Certificate of Analysis | Aug 16, 2023 | C108307 |
H2330217 | Certificate of Analysis | Aug 16, 2023 | C108307 |
D2328181 | Certificate of Analysis | Apr 01, 2023 | C108307 |
D2328187 | Certificate of Analysis | Apr 01, 2023 | C108307 |
D2328198 | Certificate of Analysis | Apr 01, 2023 | C108307 |
D2328205 | Certificate of Analysis | Apr 01, 2023 | C108307 |
D2328213 | Certificate of Analysis | Apr 01, 2023 | C108307 |
E2304229 | Certificate of Analysis | Apr 01, 2023 | C108307 |
D2328178 | Certificate of Analysis | Apr 01, 2023 | C108307 |
B2328204 | Certificate of Analysis | Mar 10, 2023 | C108307 |
C2324482 | Certificate of Analysis | Mar 07, 2023 | C108307 |
C2324449 | Certificate of Analysis | Mar 07, 2023 | C108307 |
K2208080 | Certificate of Analysis | Nov 16, 2022 | C108307 |
K2208083 | Certificate of Analysis | Nov 16, 2022 | C108307 |
K2208084 | Certificate of Analysis | Apr 07, 2021 | C108307 |
L22151178 | Certificate of Analysis | Apr 07, 2021 | C108307 |
Solubility | Soluble in DMSO (40 mg/mL), ethanol (25 mg/mL warm), DMF (~7 mg/mL), PBS, PH 7.2 (~0.65 mg/mL), hot water, ethyl acetate, Chloroform Hexane, and methanol. |
---|---|
Sensitivity | Moisture sensitive,Air sensitive |
Melt Point(°C) | 194-198°C |
Pictogram(s) | GHS08, GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H319:Causes serious eye irritation H351:Suspected of causing cancer |
Precautionary Statements | P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P405:Store locked up. P501:Dispose of contents/container to ... P203:Obtain, read and follow all safety instructions before use. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P318:if exposed or concerned, get medical advice. P337+P317:If eye irritation persists: Get medical help. |
WGK Germany | 3 |
RTECS | GD8950000 |
Merck Index | 1635 |
Starting at $135.90
Starting at $22.90
Starting at $377.90
Starting at $138.90
Starting at $69.90
Starting at $332.90
Starting at $21.90
Starting at $75.90
Starting at $266.90
Starting at $49.90
Starting at $69.90
Starting at $356.90
Starting at $249.90
Starting at $9.90
Starting at $47.90
Starting at $69.90
Starting at $30.90